TAAR1 and COVID-19: In general, the reports regarding the effectiveness of Tα1 in COVID-19 are pretty limited although Tα1 was clinically applied as an adjuvant therapy in severely or critically infected patients at the beginning of the SARS-CoV-2 outbreak.